Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $31,800 - $37,920
4,000 Added 19.18%
24,856 $227,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $50,647 - $88,226
7,383 Added 54.8%
20,856 $168,000
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $59,741 - $84,188
-8,095 Reduced 37.53%
13,473 $101,000
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $158,093 - $202,523
21,568 New
21,568 $203,000
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $162,194 - $209,210
-20,531 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $52,768 - $64,103
-6,297 Reduced 23.47%
20,531 $200,000
Q2 2021

Aug 24, 2021

BUY
$9.9 - $11.56 $72,517 - $84,677
7,325 Added 37.56%
26,828 $266,000
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $201,661 - $249,833
19,503 New
19,503 $225,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $159,732 - $204,814
-18,552 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $158,990 - $235,424
18,552 New
18,552 $167,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $382,208 - $617,558
-47,070 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $112,920 - $227,022
16,879 Added 55.91%
47,070 $423,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $99,811 - $163,855
15,285 Added 102.54%
30,191 $296,000
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $91,820 - $143,097
14,906 New
14,906 $103,000
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $400,577 - $514,477
-25,711 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $118,966 - $194,391
8,154 Added 46.44%
25,711 $396,000
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $369,750 - $450,337
17,557 New
17,557 $378,000
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $258,861 - $381,423
-15,436 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $257,472 - $340,672
15,436 New
15,436 $264,000
Q3 2017

Nov 14, 2017

SELL
$15.41 - $32.17 $124,096 - $259,065
-8,053 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
8,053
8,053 $268,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Flow Traders U.S. LLC Portfolio

Follow Flow Traders U.S. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flow Traders U.S. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flow Traders U.S. LLC with notifications on news.